GS Investments’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.72M | Buy |
9,607
+13
| +0.1% | +$7.05K | 2.7% | 8 |
|
|
2025
Q4 | $5.56M | Sell |
9,594
-3,031
| -24% | -$1.71M | 3.02% | 8 |
|
|
2025
Q3 | $6.12M | Buy |
12,625
+22
| +0.2% | +$10.2K | 3.03% | 9 |
|
|
2025
Q2 | $5.11M | Buy |
12,603
+10
| +0.1% | +$4.18K | 2.26% | 15 |
|
|
2025
Q1 | $6.27M | Buy |
12,593
+1
| +0% | +$542 | 2.95% | 7 |
|
|
2024
Q4 | $6.55M | Sell |
12,592
-178
| -1% | -$97.9K | 2.96% | 9 |
|
|
2024
Q3 | $7.9M | Hold |
12,770
| – | – | 3.52% | 4 |
|
|
2024
Q2 | $7.06M | Sell |
12,770
-23
| -0.2% | -$13.2K | 3.33% | 8 |
|
|
2024
Q1 | $7.44M | Buy |
12,793
+5
| +0% | +$2.81K | 3.59% | 4 |
|
|
2023
Q4 | $6.79M | Hold |
12,788
| – | – | 3.55% | 4 |
|
|
2023
Q3 | $6.47M | Buy |
12,788
+20
| +0.2% | +$10.7K | 3.69% | 4 |
|
|
2023
Q2 | $6.66M | Sell |
12,768
-22
| -0.2% | -$11.9K | 3.63% | 4 |
|
|
2023
Q1 | $7.37M | Sell |
12,790
-52
| -0.4% | -$29.3K | 4.26% | 3 |
|
|
2022
Q4 | $7.07M | Buy |
12,842
+16
| +0.1% | +$8.48K | 4.37% | 2 |
|
|
2022
Q3 | $6.5M | Sell |
12,826
-45
| -0.3% | -$25.2K | 4.31% | 3 |
|
|
2022
Q2 | $7.54M | Sell |
12,871
-60
| -0.5% | -$33K | 4.33% | 4 |
|
|
2022
Q1 | $7.04M | Buy |
12,931
+2
| +0% | +$1.15K | 3.98% | 3 |
|
|
2021
Q4 | $8.63M | Sell |
12,929
-25
| -0.2% | -$15.6K | 4.17% | 3 |
|
|
2021
Q3 | $7.4M | Buy |
+12,954
| New | +$7.11M | 3.88% | 3 |
|
|
2021
Q1 | – | Sell |
-6,363
| Closed | -$2.96M | – | 117 |
|
|
2020
Q4 | $2.96M | Buy |
+6,363
| New | +$2.98M | 2.87% | 9 |
|
|
2020
Q3 | – | Sell |
-13,869
| Closed | -$5.03M | – | 108 |
|
|
2020
Q2 | $5.03M | Sell |
13,869
-3,698
| -21% | -$1.24M | 4% | 5 |
|
|
2020
Q1 | $4.98M | Sell |
17,567
-270
| -2% | -$85.1K | 4.89% | 3 |
|
|
2019
Q4 | $3.69M | Sell |
17,837
-65
| -0.4% | -$19.7K | 3.06% | 7 |
|
|
2019
Q3 | $5.21M | Hold |
17,902
| – | – | 3.82% | 4 |
|
|
2019
Q2 | $527K | Sell |
17,902
-25
| -0.1% | -$6.89K | 0.43% | 52 |
|
|
2019
Q1 | $4.91M | Sell |
17,927
-120
| -0.7% | -$29.9K | 3.85% | 4 |
|
|
2018
Q4 | $4.04M | Buy |
18,047
+10
| +0.1% | +$2.35K | 3.39% | 5 |
|
|
2018
Q3 | $4.4M | Sell |
18,037
-100
| -0.6% | -$23K | 3.08% | 5 |
|
|
2018
Q2 | $3.76M | Sell |
18,137
-382
| -2% | -$81.1K | 2.8% | 8 |
|
|
2018
Q1 | $3.82M | Buy |
18,519
+70
| +0.4% | +$14.7K | 2.8% | 8 |
|
|
2017
Q4 | $3.5M | Buy |
18,449
+22
| +0.1% | +$4.21K | 2.67% | 8 |
|
|
2017
Q3 | $2.39M | Sell |
18,427
-260
| -1% | -$47.1K | 1.91% | 19 |
|
|
2017
Q2 | $3.26M | Buy |
+18,687
| New | +$3.14M | 2.44% | 9 |
|
Other funds holding TMO
VCM
GS Investments's TMO Position: Q1 2026 in Review
GS Investments increased its Thermo Fisher Scientific (TMO) stake by 0.14% in Q1 2026, buying an estimated $7.05K and bringing the position to 9,607 shares worth $4.72M. The position accounts for 2.7% of the portfolio, ranked #8.
GS Investments first reported a position in TMO in Q2 2017 and has held it in 33 quarters since. The position peaked at $8.63M in Q4 2021. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- GS Investments held 9,607 shares of Thermo Fisher Scientific worth $4.72M as of Q1 2026.
- GS Investments bought 13 Thermo Fisher Scientific shares in Q1 2026, an estimated $7.05K.
- Thermo Fisher Scientific made up 2.7% of GS Investments's portfolio in Q1 2026, its #8 holding.
- GS Investments first reported a position in Thermo Fisher Scientific in Q2 2017 and has held it in 33 quarters since.
- GS Investments's Thermo Fisher Scientific position peaked at $8.63M in Q4 2021.
- 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on GS Investments's 13F filing for Q1 2026, filed 6 May 2026.